Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01804530
Title Phase 1 Study of PLX7486 as Single Agent and With Gemcitabine Plus Nab-Paclitaxel in Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Plexxikon
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Ronald Reagan UCLA Medical Center Los Angeles California 90095 United States Details
John Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21231 United States Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field